Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 05, 2018 07:30 ET | Source: Evolus

Evolus Phase III European - Canadian Head-to-Head Trial of prabotulinumtoxinA Compared to Botox® Meets Primary Endpoint

IRVINE, Calif., April 05, 2018 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ:EOLS) (“Evolus”), a medical aesthetics company focused on delivering advanced aesthetic procedures and treatments to...
March 29, 2018 07:30 ET | Source: Evolus

Evolus Reports Fourth Quarter and Full Year 2017 Financial Results

IRVINE, Calif., March 29, 2018 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ:EOLS) (“Evolus” or the “Company”), a medical aesthetics company focused on delivering advanced aesthetic procedures and...